IntegraGen Logo

IntegraGen

Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.

ALINT | PA

Overview

Corporate Details

ISIN(s):
FR0010908723
LEI:
969500CQD8K0BUIGDH55
Country:
France
Address:
5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

IntegraGen, an OncoDNA group company, specializes in the genomics of cancer and rare genetic diseases. The company's mission is to translate molecular research into clinical practice through the development and commercialization of molecular diagnostic tests derived from the identification of genetic biomarkers. It provides expert genomic analysis and interpretable data services to academic researchers, private laboratories, and other life sciences organizations, aiming to advance both research and patient care.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 17:45
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 352.0 KB
2025-10-06 18:30
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 238.4 KB
2025-04-29 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 351.8 KB
2025-04-29 18:00
Earnings Release
Inside Information / News release on accounts, results
English 356.4 KB
2025-01-15 18:44
Earnings Release
Inside Information / Information on annual revenues
English 214.4 KB
2025-01-15 18:44
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 215.6 KB
2024-10-17 18:29
Earnings Release
Inside Information / News release on accounts, results
English 343.2 KB
2024-10-17 18:29
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 398.7 KB
2024-07-18 18:44
Earnings Release
Inside Information / Other news releases
English 270.7 KB
2024-07-18 18:44
Earnings Release
Informations privilégiées / Autres communiqués
French 268.3 KB
2024-04-18 18:00
Earnings Release
Inside Information / News release on accounts, results
English 372.7 KB
2024-04-18 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 419.4 KB
2024-01-16 17:45
Earnings Release
Inside Information / Information on annual revenues
English 307.9 KB
2024-01-16 17:45
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 269.3 KB
2023-10-19 18:15
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 332.6 KB

Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IntegraGen

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IntegraGen via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Predictive Oncology Inc. Logo
AI platform uses a vast tumor biobank to predict drug response and accelerate oncology discovery.
United States of America POAI
Prime Medicine, Inc. Logo
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America PRME
ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America PRPH
PROTHENA CORP PUBLIC LTD CO Logo
Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.
United States of America PRTA
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America 950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
Qualigen Therapeutics, Inc. Logo
A clinical-stage company developing innovative treatments for rare cancers in adults and children.
United States of America QLGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.